fundvisualizer.com

MainStay WMC Value AMAPAX

Performance (before sales charge)

As of 08/31/2022

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 07/31/2022
Stock
92.96%
Non-U.S. Stock
5.09%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
1.85%
Other
0.10%

Due to rounding, percentages may not equal 100%.

Sectors

As of 07/31/2022

Basic materials

1.05%

Consumer cyclical

7.23%

Financial services

17.74%

Real estate

5.14%

Consumer defensive

3.97%

Health care

18.29%

Utilities

5.78%

Communication services

9.19%

Energy

5.72%

Industrials

13.16%

Technology

10.79%

Top 10 holdings

As of 07/31/2022

Pfizer Inc
3.02%
JPMorgan Chase & Co
2.69%
Meta Platforms Inc Class A
2.40%
Alphabet Inc Class C
2.33%
Cisco Systems Inc
2.23%
Morgan Stanley
2.04%
Analog Devices Inc
2.02%
MetLife Inc
1.98%
M&T Bank Corp
1.98%
Eli Lilly and Co
1.95%
Fund assets

$994.09 Million

Share class

A

Morningstar category

Large Value

Expense ratio

1.02%

Investment objective

Growth

Documents